Durability of Antibody Levels After Vaccination With mRNA SARS-CoV-2 Vaccine in Individuals With or Without Prior Infection.

Zhong, Diana; Xiao, Shaoming; Debes, Amanda K; Egbert, Emily R; Caturegli, Patrizio; Colantuoni, Elizabeth; Milstone, Aaron M

Zhong, Diana; Xiao, Shaoming; Debes, Amanda K; Egbert, Emily R; Caturegli, Patrizio; Colantuoni, Elizabeth; Milstone, Aaron M.

Zhong D; Johns Hopkins University School of Medicine, Baltimore, Maryland.
Xiao S; Johns Hopkins University School of Medicine, Baltimore, Maryland.
Debes AK; Johns Hopkins School of Public Health, Baltimore, Maryland.
Egbert ER; Johns Hopkins University School of Medicine, Baltimore, Maryland.
Caturegli P; Johns Hopkins University School of Medicine, Baltimore, Maryland.
Colantuoni E; Johns Hopkins School of Public Health, Baltimore, Maryland.
Milstone AM; Johns Hopkins University School of Medicine, Baltimore, Maryland.

JAMA ; 326(24): 2524-2526, 2021 12 28.

Article in English | MEDLINE | ID: covidwho-1627553

Subject(s)

COVID-19 Vaccines/immunology; COVID-19/immunology; Immunoglobulin G/blood; Spike Glycoprotein, Coronavirus/immunology; Adult; COVID-19/diagnosis; COVID-19 Nucleic Acid Testing; COVID-19 Vaccines/administration & dosage; Confidence Intervals; Female; Health Personnel; Humans; Immunization, Secondary; Longitudinal Studies; Male; Middle Aged; Time Factors

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Immunoglobulin G / Spike Glycoprotein, Coronavirus / COVID-19 Vaccines / COVID-19 Type of study: Cohort study / Diagnostic study / Observational study / Prognostic study Topics: Vaccines Limits: Adult / Female / Humans / Male / Middle aged Language: English Journal: JAMA Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google